Canagliflozin vs Glutathione
A side-by-side research comparison of Canagliflozin and Glutathione across mechanism, dosing, half-life, benefits, side effects and research status.
Comparison table
| Attribute | Canagliflozin | Glutathione |
|---|---|---|
| Full name | Canagliflozin (SGLT2 Inhibitor) | L-Glutathione (Reduced) |
| Category | Anti-Aging | Anti-Aging |
| Status | FDA-approved drug | Supplement / Injectable |
| Mechanism | Blocks the sodium-glucose cotransporter 2 in the kidney, causing excess glucose to be excreted in urine. This lowers blood glucose independent of insulin, reduces blood pressure and weight, and produces cardio-renal protective effects. | Directly neutralizes free radicals, regenerates vitamins C and E, supports phase II liver detoxification, maintains cellular redox balance, and protects mitochondrial DNA. |
| Molecular weight | 444.52 Da | 307.32 Da |
| Half-life | ~11-13 hours | ~1.5-2 hours (IV/IM) |
| Bioavailability | ~65% oral | ~95% injectable; low oral (~3%) |
| Typical dose | 100-300 mg per day | 200-600 mg |
| Frequency | Once daily | 1-3x per week |
| Route | Oral tablet | IV push, IM injection, or nebulized |
Canagliflozin reported benefits
- Insulin-independent glucose lowering
- Cardiovascular protection
- Kidney protection
- Blood pressure reduction
- Weight loss
- Longevity signal (ITP data)
Glutathione reported benefits
- Powerful antioxidant protection
- Liver detoxification support
- Skin brightening
- Immune system support
- Anti-aging cellular protection
- Heavy metal chelation
Related comparisons
Research and educational reference only. Not medical advice.